423
Participants
Start Date
March 31, 2010
Primary Completion Date
February 28, 2011
Study Completion Date
March 31, 2011
MEN16132 - 0.125 mg
Intra-articular administration of two low doses of MEN16132 at 2-week interval.
MEN16132 - 0.25 mg
Intra-articular injection of two intermediate doses of MEN16132 at 2-week interval
MEN16132 - 0.5 mg
Intra-articular injection of two high doses of MEN16132 at 2-week interval
MEN16132 - 0.5 mg
Single intra-articular injection of one high dose of MEN16132, followed by one dose of placebo at 2-week interval
Placebo
Intra-articular injection of 2 doses of Placebo control at 2-week interval
Klinik für Rheumatologie und Klinische Immunologie, Charité - Campus Charité Mitte, Berlin
Orthopädische Praxis Dr. Wagenitz, Berlin
Rheumatologie/Immunologie - Rheumazentrum, Krankenhaus Doberan, Bad Doberan
Clinical Research Hamburg, Hamburg
Orthopädie Zentrum Altona, Hamburg
Servicio de Reumatologia, Hospital Universitario La Paz, Madrid
Department of Rheumatology, Purpan University Hospital, Toulouse
ClinPharm Prüfzentrum Magdeburg, Magdeburg
Servizio di Reumatologia, Ospedale Privato Accreditato Nigrisoli, Bologna
Servicio de Reumatologia, Hospital Universitario Virgen Macarena, Seville
ClinPharm International, Prüfzentrum Bochum, Bochum
Centre Hospitalier Régional - Hôpital Porte Madeleine, Orléans
Servicio de Reumatologia, Hospital de Basurto, Bilbao
Dipartimento di Biomedicina - SOD Reumatologia - Azienda Ospedaliera Universitaria Careggi, Florence
"Istituto di Reumatologia, Policlinico Le Scotte Università degli Studi di Siena", Siena
Dipartimento di Medicina Interna Azienda Ospedaliero Universitaria Pisana-Stabilimento di Santa Chiara Pisa, Pisa
ClinPharm Prüfzentrum Frankfurt / aM, Frankfurt
Hôtel Dieu - GHU Ouest, Paris
Medizinische Klinik 3, Universität Erlangen-Nürnberg, Erlangen
ClinPharm International, Prüfzentrum Dresden, Dresden
ClinPharm Prüfzentrum Görlitz, Görlitz
ClinPharm International, Prüfzentrum Leipzig, Leipzig
Servicio de Reumatologia, Corporacio Sanitaria Parc Tauli, Hospital de Sabadell, Sabadell
Lead Sponsor
Menarini Group
INDUSTRY